Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Human Genetics|October 26, 2005
Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical associationE K Tan, K Y Puong, D K Y Chan, et al.Acta Neurologica Scandinavica|December 3, 2009
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular diseaseK Narasimhalu, S Effendy, C H Sim, et al.European Journal of Neurology|March 4, 2020
Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's diseaseX Huang, M-C Wen, S Y-E Ng, et al.Journal of the Neurological Sciences|November 11, 2003
Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic ChineseE-K Tan, C Tan, S M C Fook-Chong, et al.Neurology|January 14, 2004
Alpha-synuclein haplotypes implicated in risk of Parkinson's diseaseE K Tan, A Chai, Y Y Teo, et al.Neurology|August 11, 2010
Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locusE-K Tan, H-H Kwok, H-K Kwok, et al.Neurosci|November 1, 2024
Intraoperative Fluorescein Sodium in Pediatric Neurosurgery: A Preliminary Case Series from a Singapore Children's HospitalAudrey J L Tan, Min Li Tey, Wan Tew Seow, et al.Diabetes Research and Clinical Practice|October 25, 2011
Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitorsYi-Ming Mu, Anoop Misra, John M F Adam, et al.Neurology|July 28, 2004
Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohortE K Tan, Y Zhao, K Y Puong, et al.Neuroscience Letters|June 16, 2005
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patientsE K Tan, H Shen, L C S Tan, et al.Pageof 15